Her main research concerns Pathology, Cerebrospinal fluid, Internal medicine, Biomarker and Dementia. Her Pathology research incorporates themes from Multiple sclerosis and Magnetic resonance imaging. The various areas that Charlotte E. Teunissen examines in her Cerebrospinal fluid study include Tau protein, Amyloid β, Disease, Csf biomarkers and Memory clinic.
She has included themes like Gastroenterology and Oncology in her Internal medicine study. Charlotte E. Teunissen interconnects Total tau, Pathological, Immunology and Frontotemporal dementia in the investigation of issues within Biomarker. Her study in Dementia is interdisciplinary in nature, drawing from both Alzheimer's disease, Apolipoprotein E, Neurology and Cohort.
Her primary scientific interests are in Internal medicine, Cerebrospinal fluid, Disease, Pathology and Dementia. Her Internal medicine research incorporates elements of Endocrinology and Oncology. Her Cerebrospinal fluid research is multidisciplinary, relying on both Total tau, Csf biomarkers, Amyloid beta, Gastroenterology and Proteomics.
The Disease study combines topics in areas such as Immunology, Bioinformatics and Intensive care medicine. Her research in Pathology intersects with topics in Multiple sclerosis and Magnetic resonance imaging. Her Dementia study combines topics in areas such as Alzheimer's disease, Apolipoprotein E, Neurology and Cognition.
Her primary scientific interests are in Internal medicine, Disease, Dementia, Cerebrospinal fluid and Biomarker. The concepts of her Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Oncology. Her work carried out in the field of Disease brings together such families of science as Proteomics, Bioinformatics and Intensive care medicine.
Her Dementia research is multidisciplinary, incorporating elements of Body mass index, Cognition and Hazard ratio. The various areas that Charlotte E. Teunissen examines in her Cerebrospinal fluid study include Amyloid beta, Csf biomarkers, Genome-wide association study, Genotype and Positron emission tomography. Her Biomarker research integrates issues from Multiple sclerosis, Neurology, Area under the curve and Pathology.
Charlotte E. Teunissen spends much of her time researching Internal medicine, Dementia, Cerebrospinal fluid, Biomarker and Disease. Her biological study spans a wide range of topics, including Gastroenterology, Neurology and Oncology. Her work deals with themes such as Genome-wide association study, Cognition, Neuroimaging, Biomarker discovery and Cohort, which intersect with Dementia.
Her study with Cerebrospinal fluid involves better knowledge in Pathology. Her Biomarker study integrates concerns from other disciplines, such as Interquartile range, Hazard ratio, Metabolome, Multiple sclerosis and Age related disease. Her Disease research is multidisciplinary, relying on both Area under the curve, Bioinformatics, Proteomics and Type 2 diabetes.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
Charlotte Teunissen;Axel Petzold;Jeffrey L. Bennett;Frode S. Berven.
Neurology (2009)
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Daphne Y S Vogel;Elly J F Vereyken;Judith E Glim;Priscilla D A M Heijnen.
Journal of Neuroinflammation (2013)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil;Charlotte E. Teunissen;Markus Otto;Fredrik Piehl.
Nature Reviews Neurology (2018)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai.
Alzheimers & Dementia (2011)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
Hugo Vanderstichele;Mirko Bibl;Sebastiaan Engelborghs;Nathalie Le Bastard.
Alzheimers & Dementia (2012)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson;Niklas Mattsson;Ulf Andreasson;Staffan Persson;Maria C. Carrillo.
Alzheimers & Dementia (2013)
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis
Charlotte E Teunissen;Christine Dijkstra;Chris Polman.
Lancet Neurology (2005)
Macrophages and neurodegeneration
Jerome J.A. Hendriks;Charlotte E. Teunissen;Helga E. de Vries;Christine D. Dijkstra.
Brain Research Reviews (2005)
Optimizing patient care and research: the Amsterdam Dementia Cohort
Wiesje M van der Flier;Yolande A L Pijnenburg;Niels Prins;Afina W Lemstra.
Journal of Alzheimer's Disease (2014)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo;Brit Mollenhauer;Antonio Bertolotto;Sebastiaan Engelborghs.
Biomarkers in Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Vrije Universiteit Amsterdam
Vrije Universiteit Amsterdam
Maastricht University
University College London
University of Gothenburg
University of Gothenburg
Vrije Universiteit Amsterdam
Vrije Universiteit Brussel
Beta
Vrije Universiteit Amsterdam
IBM (United States)
École Polytechnique
Qualcomm (United States)
University of Zaragoza
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
University of Notre Dame
National Institute for Biotechnology and Genetic Engineering
University of Pennsylvania
New Mexico Institute of Mining and Technology
Simon Fraser University
Mayo Clinic
Université Laval
KU Leuven
Mayo Clinic
Boston University
California Institute of Technology